Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Incyte Corporation (INCY) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Incyte Corporation (INCY) trades at $120.52, down 0.45% on the day but maintains strong momentum with a 23% gain year-to-date in 2026. The stock shows bullish technical signals with moving averages supporting upward trends, while recent Q2 2026 earnings beat expectations with EPS of $3.09 versus $2.15 estimate. Revenue growth continues with 2025 reaching $5.14B and projected 2026 revenue of $5.8B, supported by strong product sales including Jakafi and Opzelura.
Outlook remains positive with analyst consensus price target of $122.82 representing 1.9% upside potential. Key opportunities include continued revenue growth and recent EU approval for Opzelura, while risks involve competitive pressures and the stock's proximity to 52-week highs. The company's strong profitability metrics with 27.71% net margin and 30.67% ROE support fundamental strength.
Read full analysis

Key Stats

  • Market Cap
    $24.48B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $129.93
  • 52W Low
    $81.66
  • Typical Hold Time
    -
  • Enterprise Value
    $19.98B
  • Div Yield
    -
  • Trading Activity
    -
$120.55
52W Low: $81.66
25 Sep 2025
52W High: $129.93
28 Jul 2026

Track Incyte Corporation (INCY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Incyte Corporation has traded between a low of $81.66 and a high of $129.93, highlighting its annual price range. Buy and sell Incyte Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $24.48B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $129.93
  • 52W Low
    $81.66
  • Typical Hold Time
    -
  • Enterprise Value
    $19.98B
  • Div Yield
    -
  • Trading Activity
    -
$120.55
52W Low: $81.66
25 Sep 2025
52W High: $129.93
28 Jul 2026

Track Incyte Corporation (INCY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Incyte Corporation has traded between a low of $81.66 and a high of $129.93, highlighting its annual price range. Buy and sell Incyte Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!